MedTrace Logo

DoD-NCI TRICARE Feasibility Study

NCT02339025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2019-09-26

No results posted yet for this study

Summary

Background:

\- Researchers at the National Cancer Institute and the Department of Defense are trying to learn more about what causes cancer, heart disease, and other health problems. To do this, they gather data on risk factors and biological markers. They get these data from large groups of people in long-running studies. As these groups of people age, researchers must form new groups. TRICARE is a health insurance program for uniformed service members and their families. It is a major part of the Military Health System. Researchers hope to form a new study group from TRICARE members. This study will test if TRICARE members will take part in a research study.

Objectives:

\- To test if TRICARE members will take part in a research study.

Eligibility:

\- TRICARE members aged 35 74 with military primary care providers at Walter Reed National Military Medical Center. They must not have a prior diagnosis of cancer other than non-melanoma skin cancer.

Design:

* Participants will fill out a survey. It will ask about their risk factors for cancer and other chronic diseases. Their medical records will be reviewed. They will give a blood sample.
* If a larger study is formed, then participants data will be used in the larger study. They may be asked to give more samples.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Catherine Schairer, Ph.D. · National Cancer Institute (NCI)

Eligibility

Min Age
35 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-18
Primary Completion
2019-09-23
Completion
2019-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339025 on ClinicalTrials.gov